Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
about
Methods for administering subcutaneous heparin during pregnancyMethods for administering subcutaneous heparin during pregnancyNeuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutionsEfficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.Low molecular weight heparin treatment in pregnant women with a mechanical heart valve prosthesisPerinatal stroke--risk factors and management.Successful use of danaparoid in two pregnant women with heart valve prosthesis and heparin-induced thrombocytopenia Type II (HIT).Enoxaparin use in pregnancy: state of the art.Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.Pregnancy and congenital heart diseaseAntithrombotic therapy in patients with prosthetic heart valvesThe role of aspirin in women's healthVasoactive exposures during pregnancy and risk of microtia.Prosthetic heart valve thrombosis, anticoagulation and pregnancy: a case report and review of literature.Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.Drug insight: an overview of current anticoagulation therapy after heart valve replacement.Update on the diagnosis and management of pulmonary embolism.First trimester stroke prophylaxis in pregnant women with a history of stroke.Critical care of the obstetric patient.Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.Investigational treatments of venous thromboembolism.Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy useChallenges in managing anticoagulant therapy in patients with heart valve prostheses.Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.Pregnancy and thrombophilia.Pregnancy and adult congenital heart disease.Outpatient-based primary and secondary thromboprophylaxis with low-molecular-weight heparin.Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.Peripartum cardiomyopathy: review of the literature.Optional vena cava filters: what, why, and when.Thromboembolic events in pregnancy: pharmacological prophylaxis and treatment.Acute Coronary Syndrome During Pregnancy: A Case Report and Literature Review.Pulmonary arterial hypertension and pregnancy.The management of rheumatic diseases in pregnancyAcute neurological issues in pregnancy and the peripartum.Presentation and management of acute hypertriglyceridemic pancreatitis in pregnancy: A case report.New developments in lupus-associated antiphospholipid syndrome.Mitral valve disease in pregnancy: outcomes and management.Venous thromboembolism in women.Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience.
P2860
Q24198812-D15E4752-8077-41C0-8F9A-4A02ECE1A420Q24234862-2B38DA85-5706-4250-846C-09599301D268Q26782931-551D21AB-1E71-4C49-95B3-D91720C89CF1Q27690881-F6590F7B-A91E-41AC-A013-89E8E874A2D2Q28222467-584ACB84-C151-491F-802A-D0AC7901B18DQ30996238-3D388042-8D4A-4BC7-A5BA-B8B99D88F977Q33381436-5C053769-E496-4D22-B899-B5EE51EB875FQ33386499-13DC456B-B4C4-4472-990A-FBAC94BDC7D8Q33393738-D7A66CC8-D301-4310-AE10-23FA7C63F0ACQ34367032-269F5AFB-1C16-4E4A-8DA1-52E847AE7309Q34735887-827FE260-A86E-4AB8-8724-38FE026F3DFEQ35119642-A2C8579C-BD43-40B0-9F6D-B2700C3A6989Q35906721-E6F0CD25-2F80-4D5A-8365-4294E9507CCFQ36015645-D7AA91FC-56F4-4F9A-9384-8362A65BA435Q36163207-DAB26156-DA27-46F1-A6CC-FD09A4D38CA9Q36239522-06C70D46-ADA6-47E2-82AC-1D155D0011C7Q36286443-0C88BA98-3585-465B-9C69-37713848349AQ36579925-D6CBD6FB-F1E4-450F-8C01-710CC2479D5CQ36583288-989FE840-1787-4131-8A86-BA1D1AB5DBFEQ36590932-FA913F5A-0AA7-4C87-8D0B-E03EFAE6D0D1Q36764001-7372E254-A6E1-4A87-870E-F7A396F2CE2BQ36800361-B6ADADA3-BFAA-4DCC-A3B9-EE766C448F13Q36815991-3DE20A5A-B27B-4A67-8889-CF9E8B1EA0EBQ36832922-BB057E3E-4765-4635-9B3E-5E0430325C02Q36867306-F3DD1F97-6DB6-4998-A574-A7816DAFE4DAQ36941833-63DCF673-12C4-4934-9B03-92E46473897CQ36951531-134F36ED-5F0C-4B63-BB41-01361B205F62Q36951700-646ABC77-5CF9-47BD-8D77-E5BFC4085809Q36982631-A36AF671-DFF1-465B-9D1F-7A9FC8545136Q36988467-D41C900D-434C-4A60-9BCB-B122E0F40045Q37000726-F4589019-EAC8-4472-B552-9619AF1ABA45Q37010032-530653A8-46DD-4CDD-8804-278C76DF65CFQ37034934-83A7B47E-172F-4659-89CF-83DE61B5EC7AQ37047839-718AF021-DD48-4F87-96BA-3DBFDCC99C78Q37052664-736793B4-607E-423F-BB34-6FF7AB1A2095Q37070608-DA5349F6-42D0-4369-83FC-5B16CEF95CA0Q37168035-3E0353FC-65D0-40C2-87FD-3805679CC6B3Q37186429-168E3593-F101-415E-A581-48D02435A4E0Q37238147-35FE16D6-9835-4A60-A5FF-7426E7B9FB14Q37406823-2513313F-066D-4D19-87B5-72AB1DB1A6A3
P2860
Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@ast
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@en
type
label
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@ast
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@en
prefLabel
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@ast
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@en
P2093
P1433
P1476
Use of antithrombotic agents d ...... otic and Thrombolytic Therapy.
@en
P2093
Ian A Greer
Jack Hirsh
Jeffrey S Ginsberg
Shannon M Bates
P304
P356
10.1378/CHEST.126.3_SUPPL.627S
P407
P433
P577
2004-09-01T00:00:00Z